Switch theme
Sign up to access all valuation multiples
Nihon Kohden Corp manufactures electronic medical equipment. The firm operates in four categories: physiological measuring equipment, treatment equipment, patient monitors, and other medical equipment. The patient monitors segment contributes the largest proportion of revenue and includes continuous monitoring instruments and clinical information systems. The physiological measuring equipment segment sells electroencephalographs, electrocardiographs, and diagnostic information systems. The treatment equipment segment sells defibrillators, pacemakers, ventilators, and related consumables. The other medical equipment segment sells automated hematology analyzers, ultrasound diagnostic equipment, and other laboratory equipment. Nihon Kohden generates the majority of its revenue in Japan.
1951
5.8K+
LTM Revenue $1.5B
LTM EBITDA $166M
$1.9B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Nihon Kohden has a last 12-month revenue of $1.5B and a last 12-month EBITDA of $166M.
In the most recent fiscal year, Nihon Kohden achieved revenue of $1.5B and an EBITDA of $221M.
Nihon Kohden expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Nihon Kohden valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $1.4B | $1.5B | XXX | XXX | XXX |
| Gross Profit | $725M | $704M | XXX | XXX | XXX |
| Gross Margin | 53% | 48% | XXX | XXX | XXX |
| EBITDA | $190M | $221M | XXX | XXX | XXX |
| EBITDA Margin | 14% | 15% | XXX | XXX | XXX |
| Net Profit | $156M | $114M | XXX | XXX | XXX |
| Net Margin | 11% | 8% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Nihon Kohden's stock price is JPY 1794 (or $12).
Nihon Kohden has current market cap of JPY 292B (or $1.9B), and EV of JPY 280B (or $1.9B).
See Nihon Kohden trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.9B | $1.9B | XXX | XXX | XXX | XXX | $0.56 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Nihon Kohden has market cap of $1.9B and EV of $1.9B.
Nihon Kohden's trades at 1.2x LTM EV/Revenue multiple, and 11.2x LTM EBITDA.
Analysts estimate Nihon Kohden's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Nihon Kohden and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $1.9B | XXX | XXX | XXX |
| EV/Revenue | 1.2x | XXX | XXX | XXX |
| EV/EBITDA | 10.4x | XXX | XXX | XXX |
| P/E | 19.9x | XXX | XXX | XXX |
| P/E/Growth | 1.5x | XXX | XXX | XXX |
| EV/FCF | 114.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpNihon Kohden's NTM/LTM revenue growth is 5%
Nihon Kohden's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Nihon Kohden's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Nihon Kohden's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Nihon Kohden and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 7% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 17% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 17% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.3M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 41% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Nihon Kohden acquired XXX companies to date.
Last acquisition by Nihon Kohden was XXXXXXXX, XXXXX XXXXX XXXXXX . Nihon Kohden acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Nihon Kohden founded? | Nihon Kohden was founded in 1951. |
| Where is Nihon Kohden headquartered? | Nihon Kohden is headquartered in Japan. |
| How many employees does Nihon Kohden have? | As of today, Nihon Kohden has 5.8K+ employees. |
| Who is the CEO of Nihon Kohden? | Nihon Kohden's CEO is Mr. Hirokazu Ogino. |
| Is Nihon Kohden publicy listed? | Yes, Nihon Kohden is a public company listed on TKS. |
| What is the stock symbol of Nihon Kohden? | Nihon Kohden trades under 6849 ticker. |
| When did Nihon Kohden go public? | Nihon Kohden went public in 1961. |
| Who are competitors of Nihon Kohden? | Similar companies to Nihon Kohden include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Nihon Kohden? | Nihon Kohden's current market cap is $1.9B |
| What is the current revenue of Nihon Kohden? | Nihon Kohden's last 12-month revenue is $1.5B. |
| What is the current EBITDA of Nihon Kohden? | Nihon Kohden's last 12-month EBITDA is $166M. |
| What is the current EV/Revenue multiple of Nihon Kohden? | Current revenue multiple of Nihon Kohden is 1.2x. |
| What is the current EV/EBITDA multiple of Nihon Kohden? | Current EBITDA multiple of Nihon Kohden is 11.2x. |
| What is the current revenue growth of Nihon Kohden? | Nihon Kohden revenue growth between 2023 and 2024 was 7%. |
| Is Nihon Kohden profitable? | Yes, Nihon Kohden is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
